Skip to Content
Merck
  • Effect and Mechanism Study of Sodium Houttuyfonate on Ventilator-Induced Lung Injury by Inhibiting ROS and Inflammation.

Effect and Mechanism Study of Sodium Houttuyfonate on Ventilator-Induced Lung Injury by Inhibiting ROS and Inflammation.

Yonsei medical journal (2021-05-25)
Yi Liu, Gang Tang, Jinyu Li
ABSTRACT

Ventilator-induced lung injury (VILI) is a serious complication of mechanical ventilation (MV) that increases morbidity and mortality of patients receiving ventilator treatment. This study aimed to reveal the molecular mechanism of sodium houttuyfonate (SH) on VILI. The male mice VILI model was established by high tidal volume ventilation. The cell model was established by performing cell stretch (CS) experiments on murine respiratory epithelial cells MLE-15. In addition, the JNK activator Anisomycin and JNK inhibitor SP600125 were used on VILI mice and CS-treated cells. VILI modeling damaged the structural integrity, increased apoptosis and wet-to-dry (W/D) ratio, enhanced the levels of inflammatory factors, reactive oxygen species (ROS) and malonaldehyde (MDA), and activated JNK pathway in lung tissues. SH gavage alleviated lung injury, decreased apoptosis and W/D ratio, and reduced levels of inflammatory factors, ROS and MDA, and p-JNK/JNK expression of lung tissues in VILI mice. However, activation of JNK wiped the protective effect of SH on VILI. Contrary results were found in experiments with JNK inhibitor SP600125. SH relieved VILI by inhibiting the ROS-mediated JNK pathway.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-BAK antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-BCL-2 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-Bax antibody, Mouse monoclonal, clone 6A7, purified from hybridoma cell culture